Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06409052 · ClinicalTrials.gov registry record
Endometrial Cancer, Risk Factors and Prevention Strategies: Perspectives of Patients and At-Risk Women
A clinical trial of Endometrial Cancer, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- 45
- Enrollment target
- 1
- Study location
NCT06409052 is a study of Endometrial Cancer that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 45 participants, below the 524-participant average among 181 other Endometrial Cancer trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06409052, a study of Endometrial Cancer, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- 45 participants
- Enrollment target
- 1
- Study location
Study Summary
To learn more about women's attitudes toward and knowledge about endometrial cancer and options that might decrease the risk of developing
Conditions Studied
Interventions
- BEHAVIORAL Qualitative interviews
Study Locations (1)
Texas
- MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2024-06-25 |
| Est. Completion | 2026-08-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06409052
The ClinicalTrials.gov registry entry for NCT06409052 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 524-participant average among 181 other Endometrial Cancer trials with a reported enrollment target (91% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Endometrial Cancer appearing as the primary indexed condition, and to 1 intervention - of which Qualitative interviews is the first listed.
NCT06409052 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06409052 about?
NCT06409052 is a clinical study titled "Endometrial Cancer, Risk Factors and Prevention Strategies: Perspectives of Patients and At-Risk Women". To learn more about women's attitudes toward and knowledge about endometrial cancer and options that might decrease the risk of developing
What is the current status of trial NCT06409052?
This trial is currently recruiting. The enrollment target is 45 participants. The study started on 2024-06-25. Estimated completion is 2026-08-03.
What conditions does trial NCT06409052 study?
This clinical trial studies the following conditions: Endometrial Cancer.
What interventions are being tested in trial NCT06409052?
The interventions under investigation include: Qualitative interviews (BEHAVIORAL).
Who is sponsoring clinical trial NCT06409052?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06409052 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Endometrial Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
RECRUITING · Phase 1
-
The Better, Harder, Faster, Stronger Study
RECRUITING
-
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
RECRUITING · Phase 1
-
Study of AVZO-021 in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
RECRUITING · Phase 1
-
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.